Iovance Biotherapeutics, Inc. (FRA:2LB)
Germany · Delayed Price · Currency is EUR 2.231
-0.094 (-4.04%)
Last updated: Jan 9, 2026, 2:33 PM CET
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of €836.12 million as of January 9, 2026. Its market cap has decreased by -61.77% in one year.
Market Cap
836.12M
Enterprise Value
622.65M
Revenue
213.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.23
Market Cap Chart
Since May 26, 2010, Iovance Biotherapeutics's market cap has increased from 73.63M to 836.12M, an increase of 1,035.65%. That is a compound annual growth rate of 16.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 836.12M | -9.41% |
| Dec 31, 2025 | 923.01M | -57.63% |
| Dec 31, 2024 | 2.18B | 15.73% |
| Dec 29, 2023 | 1.88B | 99.45% |
| Dec 30, 2022 | 943.75M | -64.17% |
| Dec 31, 2021 | 2.63B | -52.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |